We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Elan Pharmaceuticals Licenses Software and Databases from Genego
News

Elan Pharmaceuticals Licenses Software and Databases from Genego

Elan Pharmaceuticals Licenses Software and Databases from Genego
News

Elan Pharmaceuticals Licenses Software and Databases from Genego

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Elan Pharmaceuticals Licenses Software and Databases from Genego"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

GeneGo, Inc. has announced that Elan Pharmaceuticals, Inc. licensed its flagship data analysis suite MetaCore™. The platform will be available to all scientists in research. MetaCore is designed for functional analysis of biological and chemistry data. Elan will use MetaCore in their neurology and autoimmune programs.

“We are very pleased that Elan chose GeneGo and we have had good interactions so far,” said Julie Bryant, GeneGo’s VP of Business development. “MetaCore has substantial knowledge content coverage in the areas of CNS and autoimmune diseases, which the Elan scientists can leverage in their innovative research.”

Advertisement